This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Favorite Picks from 'The Forever Portfolio'

Clean Water: Half of the hospital beds in the world are filled right this second by people suffering from diseases related to unclean water. While the world's population has doubled since 1950, our use of water has tripled. And how much more water is there to drink? Zero change. Consequently, ever-larger portions of the planet are using water that is deemed unsafe by current U.S. standards. Stock Pick No. 6: Idexx Laboratories (IDXX) has a growing division that detects biological contaminants in water. This is not only a clean-water play but also a terrorism play. Additionally, the company has products that help diagnose illness in animals. So they are good to cats.

Auto Safety: The last time I drove, many, many people suffered. I'm sorry. Last year there were more than 1 million auto-related deaths. That number is only increasing as people all over the world participate in the rural-to-urban move taking place in all emerging economies. Stock Pick No. 7: Autoliv (ALV) has with a 7% dividend and is the leader in auto safety. It holds the patents on airbags, seatbelts, etc. The U.S. mandates that all of these products be put in cars, and other countries are only beginning to follow suit. When they do, they go to Autoliv.

Consolation prizes:

  • Chocolate: Stock Pick No. 8: Hershey (HSY)
  • See better: Stock Pick No. 9: Luxottica (LUX)
  • Avoid a pandemic: Stock Pick No. 10: Genzyme (GENZ)

I really don't like to worry. In markets like this that go up or down 5% a day, it's too stressful to be starting at a quote screen. But if you know that you are in investments with solid balance sheets that are helping solve the world's ills -- particularly as those ills get ever greater due to demographics -- then you can rest easy at night.

Sweet dreams.


Please note that due to factors including low market capitalization and/or insufficient public float, we consider Cynosure, Cutera and Intersections to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.

At the time of publication, Altucher and/or his fund was long Goldman Sachs and Autoliv, although positions may change at any time.

James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the Financial Times and the author of Trade Like a Hedge Fund, Trade Like Warren Buffett and SuperCa$h. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

4 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs